- Feb 19, 2021
Researchers identify gene implicated in neuroblastoma, a childhood cancer
A new study by Mayo Clinic researchers has identified that a chromosome instability gene, USP24, is frequently missing in pediatric patients with neuroblastoma, an aggressive form of childhood cancer. The finding provides important insight into the development of this disease. Read more: https://www.newswise.com/articles/researchers-identify-gene-implicated-in-neuroblastoma-a-childhood-cancer
- Feb 17, 2021
Risk of Hearing Loss After Chemotherapy for Childhood Cancers
New findings from researchers at Children’s Hospital Los Angeles evaluated factors associated with the development of hearing loss after chemotherapy for pediatric cancer. Read more: https://www.docwirenews.com/docwire-pick/hem-onc-picks/risk-of-hearing-loss-after-chemotherapy-for-childhood-cancers/
- Feb 12, 2021
Researchers identify potential revolutionary new drug treatment for fatal childhood cancer
A paper published today 12 Feb 2021 in the prestigious journal, Nature Communications, reveals a potential revolutionary drug combination that - in animal studies and in world first 3D models of the tumour - is "spectacularly effective in eradicating the cancer cells," according to lead researcher and paediatric oncologist Associate Professor David Ziegler, from the Children's Cancer Institute and Sydney Children's Hospital. Read more: https://www.eurekalert.org/pub_rel
- Feb 10, 2021
Zika Virus for Childhood Cancer: Medicine’s Next Big Thing?
Neuroblastoma is the most common cancer in kids under age one. In two out of three cases, the cancer has already spread to the lymph nodes by the time of diagnosis. Now, details on how researchers are using the Zika virus to treat this devastating childhood cancer. Read more: https://wgem.com/2021/02/09/zika-virus-for-childhood-cancer-medicines-next-big-thing/
- Feb 10, 2021
New drug targets for childhood cancer neuroblastoma identified
The largest single cell study to date of the childhood cancer, neuroblastoma, has discovered that all neuroblastomas arise from a single type of embryonic cell called sympathoblasts. Read more: https://www.sciencedaily.com/releases/2021/02/210205150145.htm
- Feb 9, 2021
'Miracle stories of modern medicine': Despite limited funds, pediatric cancer research succeeds
While pediatric cancer remains rare, its impact on families still is significant. Read more: https://www.today.com/health/world-cancer-day-2021-why-childhood-cancer-gets-limited-funding-t207903
- Feb 5, 2021
The children the pandemic is threatening
Pediatric cancer is a white-knuckle journey. The mountains we climb and the valleys we visit as parents of these little warriors fighting this terrible disease illustrate the inadequacies in the treatments and knowledge about these cancers -- and Covid- 19 only exacerbates that. Read more: https://www.cnn.com/2021/02/04/opinions/child-cancer-covid-opinion-marsh/index.html
- Feb 5, 2021
Gene mutations linked to worse leukemia outcomes in Hispanic and Latino children
A combination of genetic mutations may explain the higher incidence of and poorer outcomes from pediatric leukemia in Hispanic and Latino children, according to Penn State College of Medicine researchers. They said a novel therapeutic drug combination – as well as testing for these mutations – may help address the disparity. Read more: https://news.psu.edu/story/645804/2021/02/02/research/gene-mutations-linked-worse-leukemia-outcomes-hispanic-and-latino
- Feb 1, 2021
From the clinic to the lab, understanding medulloblastoma relies on molecular profiling
A pair of research papers from St. Jude Children's Research Hospital report on a medulloblastoma clinical trial that provides insights to guide treatment and shed light on relapsed disease. Read more: https://www.eurekalert.org/pub_releases/2021-01/sjcr-ftc012521.php